首页 | 本学科首页   官方微博 | 高级检索  
     


Amyloid‐β Oligomer‐Targeted Gadolinium‐Based NIR/MR Dual‐Modal Theranostic Nanoprobe for Alzheimer's Disease
Authors:Chengke Wang  Xueli Wang  Hei‐Nga Chan  Guifeng Liu  Zhenxin Wang  Hung‐Wing Li  Man Shing Wong
Abstract:While the deposition of amyloid‐β (Aβ) plaques is one of the main pathological hallmarks of incurable Alzheimer's disease (AD), Aβ oligomers have been identified as a more appealing AD biomarker due to their being more pathogenic and neurotoxic. Therefore, the development of a sensitive and effective technique for oligomeric Aβ detection and imaging is beneficial for the early detection of AD, monitoring disease progression, and assessing the efficacy of potential AD drugs. Herein, the development and investigation of the first Aβ oligomer‐specific Gd3+‐based nanoparticles (NPs), NP@SiO2@F‐SLOH as a multimodal near‐infrared imaging (NIRI)/T1‐weighted magnetic resonance imaging (MRI) contrast agent for real‐time visualization of Aβ contents in an AD mouse model is reported. Remarkably, the NP@SiO2@F‐SLOH is successfully applied for in vivo and ex vivo NIRI with high sensitivity and selectivity for Aβ oligomers and for MRI with good spatial resolution in different age groups in an AD mouse model. Furthermore, the NP probe exhibits a noticeable inhibitory effect on Aβ fibrillation and neuroprotection against Aβ‐induced toxicity indicating its desirable therapeutic potential for AD. All these results illustrate the tremendous potential of this versatile and sensitive nanomaterial as an effective theranostic MRI nanoprobe for practical use.
Keywords:β  ‐amyloid oligomers  Alzheimer's disease  dual‐modal imaging  magnetic resonance imaging  near‐infrared imaging
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号